TechNavio's analysts forecast the Global Hyaluronic Acid market to grow at a CAGR of 9.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in aging population. The Global Hyaluronic Acid market has also been witnessing the shift to shorter treatment regimens. However, the intense price competition could pose a challenge to the growth of this market.
TechNavio's report, Global Hyaluronic Acid Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hyaluronic Acid market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Ferring Pharmaceuticals Inc., Fidia farmaceutici SpA, Sanofi SA and Seikagaku Corp.
Other vendors mentioned in the report are Anika Therapeutics Inc., Contipro Biotech Sro, htl BIOTECHNOLOGY, Lifecore Biomedical LLC, Shandong Freda Biochem Co. Ltd, Teijin Pharma Ltd., TRB Chemedica International SA and Novozymes A/S.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
04. Market Research Methodology
Market Research Process
05. Scope of the Report
06. Market Landscape
06.1 Global HAMarket
Market Size and Forecast
06.2 HA Market in the US
Market Size and Forecast
06.3 Market Segmentation by Product Type
06.4 Five Forces Analysis
07. Geographical Segmentation
08. Key Leading Countries
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 FerringPharmacuticals Inc.
16.3 Sanofi SA
16.4 Seikagaku Corp.
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global HA Market 2012-2016 (US$ billion)
Exhibit 3: HA Market in the US 2012-2016 (US$ billion)
Exhibit 4: Global HA Market Segmentation based on Product Type
Exhibit 5: Business Segmentation of Ferring Pharmaceuticals Inc.
Exhibit 6: Business Segmentation of FidiaFarmaceuticiSpA
Exhibit 7: Business Segmentation of Sanofi SA
Exhibit 8: Business Segmentation of Seikagaku Corp.